| 铜绿假单胞菌；肺部感染；抗菌药；初始治疗 |
| |
| 引用本文： | 徐西琳,张波,毛梅,傅祖红,熊盛道. 铜绿假单胞菌；肺部感染；抗菌药；初始治疗[J]. 药物流行病学杂志, 2011, 0(4): 181-183 |
| |
| 作者姓名： | 徐西琳 张波 毛梅 傅祖红 熊盛道 |
| |
| 作者单位： | 华中科技大学同济医学院附属同济医院呼吸内科;广州军区武汉总医院呼吸内科; |
| |
| 摘 要： | 目的：回顾分析院内获得性铜绿假单胞菌肺部感染的耐药性及其合理初始治疗的疗效，为临床合理用药提供依据。方法：回顾性分析我院124例铜绿假单胞菌肺部感染患者的痰培养和药敏试验，并比较初始治疗的合理用药与治疗有效率及病死率的关系。结果：药敏试验结果显示对铜绿假单胞菌较为敏感的抗菌药有哌拉西林／他唑巴坦，头孢吡肟，阿米卡星，亚胺培南，头孢哌酮／舒巴坦，头孢他啶。合理初始抗菌药治疗的患者治疗有效率（82．7％），显著高于未接受合理初始治疗的患者（65．3％）（P〈0．05）；其病死率（7．7％）低于未接受合理初始治疗者（19．4％）。接受合理初始治疗的患者抗菌药联用对铜绿假单胞菌有效的死亡率显著低于接受单药治疗的患者（P〈0．05）。结论：铜绿假单胞菌肺部感染的初始治疗抗菌药选择要合理，获得药敏试验结果后应根据其结果合理选择抗菌药。
|
| 关 键 词： | 铜绿假单胞菌 肺部感染 抗菌药 初始治疗 |
Clinical Investigation of Drug Resistance of Pulmonary Infection Caused by Pseudomonas Aeruginosa |
| |
| Xu Xilin,Zhang Bo,Mao Mei,Fu Zuhong and Xiong Shengdao. Clinical Investigation of Drug Resistance of Pulmonary Infection Caused by Pseudomonas Aeruginosa[J]. Chinese Journal of Pharmacoepidemiology, 2011, 0(4): 181-183 |
| |
| Authors: | Xu Xilin Zhang Bo Mao Mei Fu Zuhong Xiong Shengdao |
| |
| Affiliation: | Xu Xilin~(1,2),Zhang Bo~2,Mao Mei~2,Xiong Shengdao~2,Fu Zuhong~1 1.Department of Respiratory Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China,2.Department of Respiratory Medicine,Wuhan General Hospital of Guangzhou Military Command |
| |
| Abstract: | Objective:To investigate the clinical characteristics and drug resistance of pseudomonas aeruginosa in pulmonary infection and provide guidance for clinical use.Method:124 cases of pulmonary infection caused by pseudomonas aeruginosa were reviewed in our hospital and the Kirby-Bauer method was used to detect the susceptibility of pseudomonas aeruginosa.Result:The patients with humoral and local immune dysfunction were susceptible to pseudomonas aeruginosa. Such drugs as tazobactam-piperacillin,cefepime,amik... |
| |
| Keywords: | Pseudomonas aeruginosa Pulmonary Infection Antibiotics |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
